查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1615307

口蹄疫疫苗市场：依产品、类型、应用和分销管道划分－2025-2030年全球预测

Foot & Mouth Disease Vaccines Market by Product (Conventional, Emergency), Type (DNA Vaccines, Inactivated Vaccines, Live Attenuated Vaccines), Application, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年口蹄疫疫苗市场规模为26.9亿美元，预计2024年将达29.3亿美元，复合年增长率为9.10%，2030年将达49.5亿美元。

口蹄疫 (FMD) 疫苗市场包括保护牲畜免受口蹄疫 (FMD) 感染的疫苗的开发、生产和分销，口蹄疫是一种影响有蹄类动物的高度传染性病毒性疾病。这些疫苗的需求源于口蹄疫的快速传播以及对动物健康和贸易的严重影响，它可能会严重扰乱农业经济和粮食安全。口蹄疫疫苗用于牛、绵羊、猪、山羊等多种牲畜，最终用途主要集中在兽医院、专业畜牧研究所和农场，用于控制和预防疫情。市场洞察揭示了几个成长要素，包括牲畜数量的增加、对畜产品的需求增加以及政府对口蹄疫疫苗的严格监管。该市场的潜在机会包括疫苗开发的技术进步，例如生产多种口蹄疫血清型的多效价疫苗，以及疫苗接种不足地区的疫苗接种覆盖范围，例如扩大目标市场。抓住这些机会的研究包括投资于提高疫苗功效和保质期的研究，以及与当地农业部建立伙伴关係以提高市场渗透率。然而，该市场也存在局限性，包括疫苗储存和分发的成本高昂，以及向农村牲畜所有者提供疫苗的后勤挑战。此外，FMD 病毒株的突变使疫苗配方变得复杂。重组疫苗的开发和用于早期检测口蹄疫疫情的增强诊断工具等领域的创新可能会取得进展，从而能够更强有力地应对疫情并推动市场成长。该市场的特点是快速成长，但由于疾病爆发而定期波动，因此需要持续的研究、政府支持和适应策略来维持市场发展。

主要市场统计
基准年[2023] 26.9亿美元
预计年份 [2024] 29.3亿美元
预测年份 [2030] 49.5亿美元
复合年增长率（%） 9.10%

市场动态：快速发展的口蹄疫疫苗市场的关键市场洞察

供需的动态交互作用正在改变口蹄疫疫苗市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球口蹄疫盛行率和发生率不断上升
    • 政府制定强制疫苗接种政策以促进动物健康
  • 市场限制因素
    • 对热不稳定性和免疫寿命缩短的担忧
  • 市场机会
    • 加大口蹄疫疫苗研发投入
    • 政府增加对口蹄疫疫苗的核准
  • 市场挑战
    • 与野生菌株重组的风险

波特五力战略工具驾驭口蹄疫疫苗市场

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解口蹄疫疫苗市场的外部影响

外部宏观环境因素对口蹄疫疫苗市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解口蹄疫疫苗市场竞争状况

对口蹄疫疫苗市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 口蹄疫疫苗市场定位矩阵供应商绩效评估

FPNV 定位矩阵是评估口蹄疫疫苗市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了口蹄疫疫苗市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对口蹄疫疫苗市场进行策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球口蹄疫的发生率和发生率均呈上升趋势
      • 政府是否有强制疫苗接种政策以促进动物健康？
    • 抑制因素
      • 对热不稳定性和短期免疫力的担忧
    • 机会
      • 增加研发投资，打造先进的口蹄疫疫苗
      • 政府对口蹄疫疫苗的核准增加
    • 任务
      • 与野生菌株重组的风险
  • 市场区隔分析
    • 产品：紧急疫苗的使用迅速增加，为意外疾病的入侵提供快速解决方案
    • 通路：兽医诊所分销口蹄疫疫苗的演变
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 口蹄疫疫苗市场：副产品

  • 传统的
  • 紧急状况

第七章 口蹄疫疫苗市场：依类型

  • DNA疫苗
  • 灭活疫苗
  • 减毒活疫苗
  • 活性病毒载体疫苗
  • 胜肽疫苗

第八章 口蹄疫疫苗市场：依应用分类

  • 牛
  • 山羊
  • 猪
  • 羊

第九章 口蹄疫疫苗市场：依通路划分

  • 政府机构
  • 兽医诊所

第十章 美洲口蹄疫疫苗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区口蹄疫疫苗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东、非洲口蹄疫疫苗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 印度免疫学公司将在海德拉巴基因谷建造新的口蹄疫疫苗设施
    • Biogenesis Bago 在对抗口蹄疫方面取得了新的里程碑
    • 印尼开始在全国接种口蹄疫疫苗
  • 战略分析和建议

公司名单

  • Bharatbiotech International Ltd.
  • Biogenesis Bago SA
  • Boehringer Ingelheim International GmbH
  • Botswana Vaccine Institute
  • Brilliant Bio Pharma
  • Brilliant Bio Pharma Pvt. Ltd.
  • China Animal Husbandry Group
  • Indian Immunologicals Ltd.
  • Inner Mongolia Biwei Antai Biotechnology Co., Ltd.
  • Inovio Pharmaceuticals, Inc.
  • Jinyu Baoling Biopharmaceutical Co., Ltd.
  • Laboratorios Bago SA
  • Limor de Colombia
  • Merck KGaA
  • Merial SAS
  • MorphoSys AG
  • QYH Biotech Co., Ltd.
  • Shenlian Biopharmaceutical（Shanghai）Co., Ltd.
  • Vallee SA
  • Vetal Animal Health Products SA
  • Veterinary Serum and Vaccine Research Institute
Product Code: MRR-4316E4E8956A

The Foot & Mouth Disease Vaccines Market was valued at USD 2.69 billion in 2023, expected to reach USD 2.93 billion in 2024, and is projected to grow at a CAGR of 9.10%, to USD 4.95 billion by 2030.

The scope of the Foot & Mouth Disease (FMD) vaccines market encompasses the development, production, and distribution of vaccines that protect livestock against FMD, a highly contagious viral disease affecting cloven-hoofed animals. The necessity for these vaccines stems from FMD's potential to significantly disrupt agricultural economies and food security due to its rapid transmission and severe implications for animal health and trade. The application of FMD vaccines ranges across various livestock, such as cattle, sheep, pigs, and goats, with end-use focused primarily on veterinary hospitals, specialized livestock research institutes, and farms to control and prevent outbreaks. Market insights reveal several growth factors, including increasing livestock population, rising demand for animal products, and stringent governmental regulations mandating FMD vaccines. Potential opportunities in this market include technological advancements in vaccine development, such as the production of multivalent vaccines that offer protection against multiple FMD serotypes, and expanding vaccine coverage geographically in regions lacking sufficient vaccine accessibility. Recommendations for capturing these opportunities involve investing in research to enhance vaccine efficacy and shelf life and forging partnerships with local agricultural ministries to broaden market penetration. However, the market also faces limitations, such as high costs associated with vaccine storage and distribution and logistical challenges in reaching rural livestock owners. Additionally, variations in FMD virus strains complicate vaccine formulation. Innovation can thrive in areas such as developing recombinant vaccines and enhancing diagnostic tools for early detection of FMD outbreaks, which would provide more robust responses to outbreaks and contribute to market growth. The market is characterized by rapid growth with periodic volatility due to disease outbreaks, thus reinforcing the need for continual research, governmental support, and adaptive strategies to sustain market advancement.

KEY MARKET STATISTICS
Base Year [2023] USD 2.69 billion
Estimated Year [2024] USD 2.93 billion
Forecast Year [2030] USD 4.95 billion
CAGR (%) 9.10%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Foot & Mouth Disease Vaccines Market

The Foot & Mouth Disease Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence and incidence of FMD outbreaks across the globe
    • Availability of government policies for mandatory vaccinations that promote animal health
  • Market Restraints
    • Concerns related to thermal instability and short-lived immunity
  • Market Opportunities
    • Increasing investments in R&D to yield advanced vaccines for FMD
    • Growing government approvals for FMD vaccines
  • Market Challenges
    • Risk of recombination with the wild strains

Porter's Five Forces: A Strategic Tool for Navigating the Foot & Mouth Disease Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Foot & Mouth Disease Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Foot & Mouth Disease Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Foot & Mouth Disease Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Foot & Mouth Disease Vaccines Market

A detailed market share analysis in the Foot & Mouth Disease Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Foot & Mouth Disease Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Foot & Mouth Disease Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Foot & Mouth Disease Vaccines Market

A strategic analysis of the Foot & Mouth Disease Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Foot & Mouth Disease Vaccines Market, highlighting leading vendors and their innovative profiles. These include Bharatbiotech International Ltd., Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Botswana Vaccine Institute, Brilliant Bio Pharma, Brilliant Bio Pharma Pvt. Ltd., China Animal Husbandry Group, Indian Immunologicals Ltd., Inner Mongolia Biwei Antai Biotechnology Co., Ltd., Inovio Pharmaceuticals, Inc., Jinyu Baoling Biopharmaceutical Co., Ltd., Laboratorios Bago S.A., Limor de Colombia, Merck KGaA, Merial S.A.S., MorphoSys AG, QYH Biotech Co., Ltd., Shenlian Biopharmaceutical (Shanghai) Co., Ltd., Vallee S.A., Vetal Animal Health Products S.A., and Veterinary Serum and Vaccine Research Institute.

Market Segmentation & Coverage

This research report categorizes the Foot & Mouth Disease Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Conventional and Emergency.
  • Based on Type, market is studied across DNA Vaccines, Inactivated Vaccines, Live Attenuated Vaccines, Live Viral Vector Vaccines, and Peptide Vaccines.
  • Based on Application, market is studied across Cattle, Goat, Pigs, and Sheep.
  • Based on Distribution Channel, market is studied across Government Institutions and Veterinary Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence and incidence of FMD outbreaks across the globe
      • 5.1.1.2. Availability of government policies for mandatory vaccinations that promote animal health
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns related to thermal instability and short-lived immunity
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investments in R&D to yield advanced vaccines for FMD
      • 5.1.3.2. Growing government approvals for FMD vaccines
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of recombination with the wild strains
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Burgeoning utilization of emergency vaccines offering a quick solution to unexpected incursions of the disease
    • 5.2.2. Distribution Channel: Evolving veterinary clinics for the distribution of foot and mouth disease vaccines
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Foot & Mouth Disease Vaccines Market, by Product

  • 6.1. Introduction
  • 6.2. Conventional
  • 6.3. Emergency

7. Foot & Mouth Disease Vaccines Market, by Type

  • 7.1. Introduction
  • 7.2. DNA Vaccines
  • 7.3. Inactivated Vaccines
  • 7.4. Live Attenuated Vaccines
  • 7.5. Live Viral Vector Vaccines
  • 7.6. Peptide Vaccines

8. Foot & Mouth Disease Vaccines Market, by Application

  • 8.1. Introduction
  • 8.2. Cattle
  • 8.3. Goat
  • 8.4. Pigs
  • 8.5. Sheep

9. Foot & Mouth Disease Vaccines Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Government Institutions
  • 9.3. Veterinary Clinics

10. Americas Foot & Mouth Disease Vaccines Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Foot & Mouth Disease Vaccines Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Foot & Mouth Disease Vaccines Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Indian Immunologicals' new facility for FMD vaccines to come up in Hyderabad's Genome Valley
    • 13.3.2. Biogenesis Bago reaches a new milestone in its fight against Foot and Mouth Disease
    • 13.3.3. Indonesia launching nationwide vaccinations for foot and mouth disease
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Bharatbiotech International Ltd.
  • 2. Biogenesis Bago SA
  • 3. Boehringer Ingelheim International GmbH
  • 4. Botswana Vaccine Institute
  • 5. Brilliant Bio Pharma
  • 6. Brilliant Bio Pharma Pvt. Ltd.
  • 7. China Animal Husbandry Group
  • 8. Indian Immunologicals Ltd.
  • 9. Inner Mongolia Biwei Antai Biotechnology Co., Ltd.
  • 10. Inovio Pharmaceuticals, Inc.
  • 11. Jinyu Baoling Biopharmaceutical Co., Ltd.
  • 12. Laboratorios Bago S.A.
  • 13. Limor de Colombia
  • 14. Merck KGaA
  • 15. Merial S.A.S.
  • 16. MorphoSys AG
  • 17. QYH Biotech Co., Ltd.
  • 18. Shenlian Biopharmaceutical (Shanghai) Co., Ltd.
  • 19. Vallee S.A.
  • 20. Vetal Animal Health Products S.A.
  • 21. Veterinary Serum and Vaccine Research Institute

LIST OF FIGURES

  • FIGURE 1. FOOT & MOUTH DISEASE VACCINES MARKET RESEARCH PROCESS
  • FIGURE 2. FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. FOOT & MOUTH DISEASE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. FOOT & MOUTH DISEASE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FOOT & MOUTH DISEASE VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FOOT & MOUTH DISEASE VACCINES MARKET DYNAMICS
  • TABLE 7. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY EMERGENCY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY LIVE VIRAL VECTOR VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PEPTIDE VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY GOAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PIGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY SHEEP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY GOVERNMENT INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 192. FOOT & MOUTH DISEASE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. FOOT & MOUTH DISEASE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023